MedInsights Unleashed

Episode Summary:

This is the second episode in our series on colorectal cancer. In this episode of MedInsights Unleashed, we sit down with Prof. Paulo Hoff, MD, PhD, from the University of São Paulo, Brazil, to discuss the latest developments in colorectal cancer treatment. With cases increasing, especially among younger adults, the conversation underscores the importance of early screening and detection. Prof. Hoff explains how tum...

Osteoporosis is often viewed as a women’s disease, but in this episode of MedInsights Unleashed, Dr. Tom Forfa, MBBS, reveals why men are also at serious risk. A retired physician and osteoporosis educator from Queensland, Australia, Dr. Forfa shares his personal journey, from multiple fractures to a delayed diagnosis, highlighting the need for early screening and awareness.

This episode uncovers misconceptions, risk factors, and tr...

In this latest episode of MedInsights Unleashed, we are delighted to welcome Dr. Paulo Hoff, MD, PhD, Professor of Clinical Oncology at the Department of Radiology and Oncology, University of São Paulo. Dr. Hoff discusses the rising incidence of colorectal cancer in younger populations, highlighting key risk factors including poor diet, sedentary lifestyle, and obesity. He emphasizes the critical importance of beginning regular scr...

In this MedInsights Unleashed episode, Dr. Christine Simmons, MD, Associate Professor in the Faculty of Medicine at UBC (University of British Columbia) and specialist in breast cancer and sarcoma, provides an in-depth exploration of the breast cancer journey, focusing on diagnosis, staging, and cutting-edge treatments for triple-negative breast cancer. She discusses the critical role of subtype differentiation and personalized car...

In this MedInsights Unleashed episode, Dr Christine Simmons MD, Associate Professor in the Faculty of Medicine at UBC (University of British Columbia) and specialist in breast cancer and sarcoma, discusses breast cancer awareness, emphasizing the importance of regular screenings for early detection—especially post-COVID-19, as screening rates have significantly dropped. Early detection leads to better outcomes and less aggressive t...

Elen Baloyan, MD, Oncology Fellow at Yeolyan Hematology and Oncology Center in Yerevan, Armenia, shares her insightful journey in this MedInsights Unleashed podcast episode. She addresses the financial toxicity affecting both doctors and patients in Armenia, which often leads to treatment refusals and late diagnoses due to high costs. Despite government efforts to support cancer care, the financial burden remains significant. Elen ...

In this episode of MedInsights Unleashed, Dr. Oliver Bathe MD FRCSC, Professor of Surgery and Oncology University, CEO Qualisure Diagnostics Inc. discusses his journey from surgical oncology to pioneering precision cancer care. He delves into the role of machine learning in analyzing vast genomic databases to personalize treatment and improve patient outcomes. Dr. Bathe shares personal insights, emphasizing the importance of tailor...

In this MedInsights Unleashed episode, Dr. Ari Rosenberg from University Chicago Medical Center, delves into the complexities and advancements in the treatment of head and neck cancers. Despite the recurrence and resistance these cancers often develop, immunotherapy has marked a significant breakthrough, especially in releasing the immune system's brakes. Although its introduction in early-stage cancer remains elusive, ongoing tria...

In this episode Professor Philippe Merle explains the interplay between chronic liver conditions and the development of HCC. The conversation highlights the significance of early diagnosis and consistent patient monitoring to catch the disease in its nascent stages. Professor Merle also discusses the evolving landscape of HCC treatments, including innovative therapies and the benefits of a multidisciplinary medical team in managing...

In this episode of Med Insights Unleashed, hosts Zee and John welcome Michael Staehler MD Ph.D, Professor of Urology at the University of Munich and Head the Interdisciplinary Center for Renal Tumors at Ludwig-Maximilian University, Munich. to discuss renal cell carcinoma. He explains how patient selection and managing side effects, including sexual dysfunction, play critical roles in effective cancer treatment. The conversation al...

In this episode, hosts Zahra and John welcome Dr. Ari Rosenberg from University Chicago Medical Center, to explore head and neck cancer, a disease affecting nearly 900,000 people annually worldwide. Dr. Rosenberg delves into the complexities of diagnosing and treating cancers in the head and neck region. The discussion highlights the significant role of HPV, particularly in oropharynx cancers, and the promising impact of HPV vaccin...

In this episode, Professor Escudier from Gustave Roussy, a major cancer center in Paris France, discusses the advances in kidney cancer treatment over the past 30 years. Professor Escudier discusses the significance of the Keynote 564, the first positive trial in adjuvant renal cell cancer. He explains how these findings impact first-line treatment decisions for metastatic kidney cancer. He discusses the differences between cure,...

In this episode, Dr. Ariel Goldman and Lewis Collins discuss the advancements in hip fracture care. They highlight the urgent need for timely surgical intervention and reveal how these practices have successfully reduced complications and mortality rates. Focusing on the aging population and osteoporosis, they stress the importance of understanding risk factors and prevention. They compare exercise forms, such as Tai Chi, to other ...

In this episode, Prof Galle, a hepatologist and Professor of Medicine at University Medical Center Mainz, Germany, has an in-depth conversation with co-hosts Zee and John of MedInsights Unleashed on the late breaking data, CM9DW, presented at ASCO 2024. The episode covers:

- **Cutting-Edge Therapies:** Explore the transformation in HCC treatment from surgery and transplantation to the latest immunotherapies. Discover h...

Professor Markus Peck-Radosavljevic, MD MBA, is Professor of Medicine and Chairman at the Department of Internal Medicine & Gastroenterology (IMuG) at Klinikum Klagenfurt in Austria. A renowned gastroenterologist and hepatologist, he discusses the importance of understanding risks in medical treatments, clear communication, and considering patient preferences in treatment decisions. Professor Peck addresses challenges in patie...

This podcast episode focuses on radioembolization and its implications in liver cancer treatment. Professor Edward Kim, Director of Interventional Oncology at Mount Sinai Health Systems, provides insights into the use of radioembolization, a minimally invasive procedure that delivers radiation directly to liver tumors. He discusses its utilization across different stages of primary liver cancer, from curative intent therapies in ea...

This transcript explores the challenges faced by both physicians and patients in accessing treatment.

Professor Vogel discusses the differences in treatment access between Germany and Canada, having experienced both healthcare systems. He highlights the restrictive criteria for liver transplantation in Germany and the limited availability of certain therapies in Canada, particularly for rare cancers like cholangiocarcinoma. The ...

MedInsights Unleashed is an exciting new podcast aimed at providing valuable information and insights for patients and healthcare professionals.

In this first episode, hosts Zahra and John are joined by Professor Arndt Vogel to discuss key data from the adjuvant setting of liver cancer. They talk about the challenges of liver cancer treatment, the high mortality rate associated with the disease, and the progress made in recent years...